Drug Enforcement Administration
Drug Enforcement Administration · page 2
- Uncategorized
DEA Under Fire: New Documents Provide Evidence of DEA’s Bias in Rescheduling Process
New court documents are said to provide new evidence of the US Drug Enforcement Administration’s bias against cannabis rescheduling, a process which it is overseeing.
- Uncategorized
DOJ Ruling on Judge Protections Could Accelerate Cannabis Research Lawsuit Against DEA
The US Department of Justice (DOJ) has determined that protections preventing the removal of Administrative Law Judges (ALJs) are unconstitutional and will no longer defend them in court, a move that could have significant implications for cannabis research.
- Uncategorized
Cannabis Rescheduling Feared ‘Dead’ Following Appointment of New DEA Administrator Maltz
Cannabis rescheduling was dealt a major blow today as it was confirmed that long-time cannabis sceptic and anti-drug veteran Derek S. Maltz has been appointed as acting administrator of the DEA.
- Cultivation
Immediate Investigation into DEA’s Conduct Demanded Ahead of Rescheduling Hearings Amid Fresh Allegations of Bias
The Drug Enforcement Administration (DEA) has come under renewed pressure to be removed from the upcoming cannabis rescheduling process amid fresh allegations of bias.
- Uncategorized
Cannabis Rescheduling Hearing Set to Begin on January 21 for 6 Weeks, As Frustrations Over Process Continue to Build
The Drug Enforcement Administration (DEA) has scheduled an official date for the highly anticipated public hearing on cannabis rescheduling, starting with a presentation from the government just a day after President Elect Donald Trump is sworn in.
- Uncategorized
Cannabis Rescheduling Hearing Delayed Until Next Year
Just days after announcing the first tranche of witnesses for the critical upcoming public hearing on cannabis rescheduling, the Drug Enforcement Administration (DEA) has postponed it until early 2025.
- Uncategorized
DEA Begins Selecting Witnesses Ahead of Critical Cannabis Rescheduling Trial
The US Drug Enforcement Administration (DEA) has announced the first witnesses due to attend the critical upcoming public hearing on cannabis rescheduling.
- Policy & Regulation
Cannabis Rescheduling Confirmed: DOJ Initiates Formal Rulemaking Process As Biden Makes it Official
President Joe Biden has officially confirmed that cannabis is set to be rescheduled from a Schedule I substance to a Schedule III.
- Uncategorized
Congressional Research Service Says DEA ‘Likely to Reschedule’ Cannabis in New Report
US congressional researchers have stated that it ‘appears likely’ the Drug Enforcement Administration (DEA) will reschedule cannabis.
- Uncategorized
Head Of US FDA Says ‘No Reason’ DEA Should Delay Cannabis Rescheduling
The head of the US Food and Drug Administration (FDA), Robert Califf, told elected officials this week that he believes there is ‘no reason for the DEA to delay’ making its decision on cannabis rescheduling.
